Janux Therapeutics (JANX)
(Delayed Data from NSDQ)
$62.43 USD
+4.24 (7.29%)
Updated May 2, 2024 04:00 PM ET
After-Market: $61.25 -1.18 (-1.89%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/14/2024
Time: -- |
3/2024 | $-0.35 | 0.00% |
Earnings Summary
For their last quarter, Janux Therapeutics (JANX) reported earnings of -$0.25 per share, beating the Zacks Consensus Estimate of $-0.37 per share. This reflects a positive earnings surprise of 32.43%. Look out for JANX's next earnings release expected on May 14, 2024. For the next earning release, we expect the company to report earnings of -$0.35 per share, reflecting a year-over-year increase of 16.67%.
Earnings History
Price & Consensus
Zacks News for JANX
Janux (JANX) Rises Almost 50% in a Week on Buyout Rumors
JANX: What are Zacks experts saying now?
Zacks Private Portfolio Services